India Pesticides Ltd Q1FY26 + FY25: From Fungicides to Fund Games, Inventory Pile-Up, and Anti-Dumping Drama
1. At a Glance
India Pesticides Ltd (IPL) looks like that classmate who topped in chemistry practicals but forgot to submit the project file. Revenue jumped 25% YoY, PAT nearly doubled, margins improved, stock up 70% in six months—yet the balance sheet groans under a 255-day cash conversion cycle. A pesticide company that can’t kill working capital pests? Now that’s irony.
2. Introduction
Founded in 1984, IPL is a chemical R&D-driven player that produces technicals, formulations, and APIs. Their pitch is simple: “We make stuff that kills pests and fungi but hopefully not your portfolio returns.”
But here’s the twist—while most agrochemical firms are busy flexing exports, IPL is still trying to balance between Punjab farmers and Australian distributors. The company exports 40% of revenues to 25+ countries, but 60% remains in Bharat, i.e., convincing Haryana khet-walas that its fungicide works better than grandpa’s neem ka paani.
The numbers in FY25 look sexy at first glance: sales at ₹883 Cr, PAT up 54%, EPS at ₹8.57. Yet, dig deeper and you see inventory mountains as tall as the Himalayas, with customers ordering last-minute instead of six months in advance. Classic MNC jugaad: pass the working capital headache to the vendor.
As if that wasn’t enough, the taxmen walked in late 2024 for a “chai-biskoot” visit, and directors resigned citing “health issues” (read: mental health after seeing debtor days rise to 152).
3. Business Model – WTF Do They Even Do?
Imagine you are Sherlock Holmes investigating a factory in Sandila, UP. You find drums labeled “Folpet,” “Captan,” and “Thiocarbamate Herbicide.” That’s their bread and butter: technical-grade agrochemicals. They supply these to giants like Adama, UPL, Rallis, Syngenta. Basically, IPL makes the raw pesticide powder, sells it to the branded boys, and they sprinkle it on your bhindi and aloo.
Formulations (the diluted, ready-to-spray stuff) make up ~28% of sales. APIs form a tiny but growing segment, largely dermatological—anti-fungal, anti-scabies creams. Because why stop at saving crops when you can also save your skin?
Key edge: They are sole Indian manufacturers for some products globally. But dependency on a handful of MNC customers means pricing power = weaker than hostel chai.
